S3, A to D), as well as in mice bearing poorly immunogenic Lewis lung carcinoma (LLC) and treated with anti–PD-L1 combined with agonist anti-CD40 antibodies (fig. Here, CD40 is linked to Carcinoma, Lewis Lung.